Surgery Websites
Thoracic Oncology Program »  Meet the Team »  Medical Oncologists »  Melisa L. Wong, M.D., M.A.S.
Melisa L. Wong, M.D., M.A.S.

Melisa L. Wong, M.D., M.A.S.

Assistant Clinical Professor
Division of Hematology/Oncology
Department of Medicine

Contact Information

Thoracic Surgery & Oncology Clinic
1600 Divisadero St., 4th Floor
San Francisco, CA 94143
(415) 885-3882 Appointments
(415) 353-7151 Clinic Fax
melisa.wong@ucsf.edu
Open Popup

Stanford University, B.A., Human Biology with Honors and Distinction, 2005

UCSF School of Medicine, M.D., 2011

UCSF Master’s Degree Program in Clinical Research, M.A.S., 2017

  • UCSF, Internship in Internal Medicine, 2011-12
  • UCSF, Residency in Internal Medicine, 2012-14
  • UCSF, Fellowship in Medical Oncology, 2014-17 (2015 Quality Chief Fellow, 2016 Chief Fellow)
  • UCSF, Aging Research T32 Fellowship, 2015-17
  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Medical Oncology
  • Department of Medicine, Division of Hematology/Oncology
  • Thoracic Oncology Program
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • Cancer outcomes research
  • Functional status
  • Geriatric oncology
  • Quality of life
  • Treatment toxicity

Melisa L. Wong, M.D., M.A.S. is a thoracic oncologist who treats patients with lung cancer and other thoracic malignancies. Dr. Wong has a particular interest in caring for older adults with cancer. Her goal is to provide personalized cancer care based on patients' values and goals.

Dr. Wong completed medical school and training in internal medicine and medical oncology at UCSF. She also completed advanced research training as an Aging Research T32 Fellow in the UCSF Division of Geriatrics and earned her Master's Degree in Clinical Research in the UCSF Department of Epidemiology and Biostatistics. Dr. Wong is a member of the American Society of Clinical Oncology, Cancer and Aging Research Group, Alliance for Clinical Trials in Oncology, International Society of Geriatric Oncology, International Association for the Study of Lung Cancer, and American Geriatrics Society.

  Award  
  Confired By    
  Date    
  • Cancer and Aging Special Interest Group Co-Chair
  • American Geriatrics Society
  • 2018
  • Junior Investigator Board
  • Cancer and Aging Research Group
  • 2018
  • Early Career Faculty Workgroup
  • Claude D. Pepper Older Americans Independence Center
  • 2018
  • Cancer and Aging Special Interest Group Chair
  • American Geriatrics Society
  • 2018 - 2020
  • Early Career Faculty Workgroup
  • Claude D. Pepper Older Americans Independence Center
  • 2018 - 2020
  • Loan Repayment Program Award
  • NIH/NCI
  • 2017 - 2020
  • Loan Repayment Program Award
  • NIH/NCI
  • 2017 - 2019
  • Vicky Merryman Women Who Conquer Cancer Young Investigator Award
  • Conquer Cancer Foundation of ASCO
  • 2017 - 2018
  • Merit Award - Annual Meeting
  • Conquer Cancer Foundation of ASCO
  • 2017
  • Merit Award - Quality Care Symposium
  • Conquer Cancer Foundation of ASCO
  • 2017
  • SIOG Young Investigator Award
  • International Society of Geriatric Oncology (SIOG)
  • 2017
  • Merit Award - Annual Meeting
  • Conquer Cancer Foundation of ASCO
  • 2016
  • Merit Award - Quality Care Symposium
  • Conquer Cancer Foundation of ASCO
  • 2016
  • Butler-Williams Scholars Program
  • National Institute on Aging
  • 2016
  • Hematology/Oncology Chief Fellow
  • UCSF
  • 2016
  • Hematology/Oncology Division Clinical Fellow Award
  • UCSF Department of Medicine
  • 2016
  • Award for Excellence in Fellowship Research
  • UCSF Hematology/Oncology Research Retreat
  • 2016
  • Cancer and Aging Research U13 Conference Young Investigator Travel Award
  • Cancer and Aging Research Group
  • 2015
  • Hematology/Oncology Quality Chief Fellow
  • UCSF
  • 2015
  • Department of Medicine Professionalism Award
  • UCSF
  • 2014
  • SOM Dean's Quarterly Research Fellowship
  • UCSF
  • 2011
  • Alpha Omega Alpha Honor Medical Society
  • UCSF
  • 2010
  • Bernard Osher Scholarship
  • UCSF
  • 2008 - 2011
  • SOM Dean's Summer Research Fellowship
  • UCSF
  • 2008
  • Joshua Lederberg Award for Academic Excellence in Human Biology
  • Stanford University
  • 2005
  • Chappell Lougee Scholarship
  • Stanford University
  • 2003
  • Dr. Wong's research focuses on understanding and improving patient-centered outcomes in older adults with cancer. She is currently studying the impact of lung cancer treatment (such as chemotherapy, immunotherapy, and targeted therapy) on patients' functional status and quality of life. Dr. Wong also studies how symptoms change over time in older adults with cancer. 

    Dr. Wong's forthcoming study, "Lung Cancer in Older Adults: Treatment Toxicity Through the Patient's Lens," will recruit UCSF lung cancer patients who are age 65 or older and starting a new chemotherapy, immunotherapy, or targeted therapy regimen. Dr. Wong and her research team will explore how lung cancer treatment impacts patients' functional status and quality of life.  

    Data provided by UCSF Profiles, powered by CTSI
    ORCID iD: 0000-0001-6390-6959 Additional info
    • Advancing patient-centered decision making in older adults with lung cancer: Incorporating risk of functional decline into treatment discussions
      Sponsor:
      Sponsor ID:
      Funding Period:
      Jul 2019
      -
      Feb 2024
    • Adaptation of the Best Case/Worst Case communication tool to geriatric oncology: Improving patient-centered decision making for older adults with lung cancer
      Sponsor:
      Sponsor ID:
      Funding Period:
      Jul 2019
      -
      Jun 2020
    • Expanding the Definition of Treatment Toxicity in Older Adults with Lung Cancer
      Sponsor:
      Sponsor ID:
      Funding Period:
      Jul 2017
      -
      May 2020
      Principal Investigator
    • UCSF CTSI KL2 Career Development Award
      Sponsor:
      Sponsor ID:
      Funding Period:
      Jul 2017
      -
      May 2020
      KL2 Scholar
    • UCSF Older Americans Independence Center Research Advanced Scholar Award
      Sponsor:
      Sponsor ID:
      Funding Period:
      Jul 2017
      -
      Jun 2019
      Research Education Core Advanced Scholar
    • Characterization of chemotherapy-induced peripheral neuropathy in older cancer survivors
      Sponsor:
      Sponsor ID:
      Funding Period:
      Jul 2017
      -
      Jun 2018
    MOST RECENT PUBLICATIONS FROM A TOTAL OF 47
    Data provided by UCSF Profiles, powered by CTSI
    1. Wong ML, Gao J, Thanarajasingam G, Sloan JA, Dueck AC, Novotny PJ, Jatoi A, Hurria A, Walter LC, Miaskowski C, Cohen HJ, Wood WA, Feliciano JL, Stinchcombe TE, Wang X. Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729). Oncologist. 2020 Sep 20. View in PubMed
    2. Maggiore RJ, Zahrieh D, McMurray RP, Feliciano JL, Samson P, Mohindra P, Chen H, Wong ML, Lafky JM, Jatoi A, Le-Rademacher JG. Toxicity and survival outcomes in older adults receiving concurrent or sequential chemoradiation for stage III non-small cell lung cancer in Alliance trials (Alliance A151812). J Geriatr Oncol. 2020 Sep 16. View in PubMed
    3. Wu SY, Lazar AA, Gubens MA, Blakely CM, Gottschalk AR, Jablons DM, Jahan TM, Wang VEH, Dunbar TL, Wong ML, Chan JW, Guthrie W, Belkora J, Yom SS. Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial. JAMA Netw Open. 2020 09 01; 3(9):e209750. View in PubMed
    4. Wong ML, Gao J, Thanarajasingam G, Sloan JA, Dueck AC, Novotny PJ, Jatoi A, Hurria A, Walter LC, Miaskowski C, Cohen HJ, Wood WA, Feliciano JL, Stinchcombe TE, Wang X. Expanding beyond maximum grade: Chemotherapy toxicity over time by age and performance status in advanced non-small cell lung cancer in CALGB 9730 (Alliance A151729). Oncologist. 2020; (In press). View in PubMed
    5. Utne I, Cooper BA, Ritchie C, Wong M, Dunn LB, Loyland B, Grov EK, Hammer MJ, Paul SM, Levine JD, Conley YP, Kober KM, Miaskowski C. Co-occurrence of decrements in physical and cognitive function is common in older oncology patients receiving chemotherapy. Eur J Oncol Nurs. 2020 Oct; 48:101823. View in PubMed
    6. View All Publications

     

    Site Directory
      X